S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses

S2-E12 — NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses

Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG session to with its focus on innovative trial design and improving histological analyses

The Friday afternoon session of NASH-TAG 2021 highlights innovation in clinical trial design and histologic analysis. Before NASH-TAG starts its Day Two, join SurfingNASH to sort out how what the data means, how the pieces fit together and what questions will require more exploration. If you send us any questions emerging from Session #2 or the podcast, we will review them in later NASH-TAG episodes and try to get feedback from those at the meeting.

Request A Transcript of This Episode
Request Transcript
First
Last

Join The Discussion…

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"